Molina Hlthcare Financials

MOH

Source SEC Filings (10-K/10-Q) Updated Feb 10, 2026 Currency USD FYE February

Financial Health Signals

Financial Profile 31/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Molina Hlthcare has an operating margin of 1.7%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 9/100, suggesting thin profitability after operating expenses. This is down from 4.2% the prior year.

Growth

Molina Hlthcare's revenue declined 100% year-over-year, from $40.6B to $45K. This contraction results in a growth score of 0/100.

Leverage

Molina Hlthcare carries a low D/E ratio of 0.93, meaning only $0.93 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 77/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Molina Hlthcare's current ratio of 1.69 indicates adequate short-term liquidity, earning a score of 48/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Molina Hlthcare's free cash flow margin of 1.0% results in a low score of 5/100. Capital expenditures of $101 absorb a large share of operating cash flow.

Returns

Molina Hlthcare's ROE of 11.6% shows moderate profitability relative to equity, earning a score of 46/100. This is down from 26.2% the prior year.

Altman Z-Score Safe

363841.55

Molina Hlthcare scores 363841.55, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($7.0B) relative to total liabilities ($11K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

6/9

Molina Hlthcare passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.13x

For every $1 of reported earnings, Molina Hlthcare generates $1.13 in operating cash flow ($535 OCF vs $472 net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.1x

Molina Hlthcare earns $4.1 in operating income for every $1 of interest expense ($781 vs $192). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

This page shows Molina Hlthcare (MOH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$45K

YoY-100.0%

5Y CAGR-92.5%

10Y CAGR-71.8%

Molina Hlthcare generated $45K in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EBITDA

$976

YoY-100.0%

5Y CAGR-93.9%

10Y CAGR-73.2%

Molina Hlthcare's EBITDA was $976 in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 100.0% from the prior year.

Free Cash Flow

$434

YoY-100.0%

5Y CAGR-95.3%

10Y CAGR-76.9%

Molina Hlthcare generated $434 in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 100.0% from the prior year.

Net Income

$472

YoY-100.0%

5Y CAGR-94.1%

10Y CAGR-71.7%

Molina Hlthcare reported $472 in net income in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EPS (Diluted)

$8.92

YoY-56.3%

5Y CAGR-4.5%

10Y CAGR+13.2%

Molina Hlthcare earned $8.92 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 56.3% from the prior year.

Cash & Debt

$4K

YoY-100.0%

5Y CAGR-93.7%

10Y CAGR-73.3%

Molina Hlthcare held $4K in cash against $4K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY-100.0%

5Y CAGR-93.8%

10Y CAGR-75.1%

Molina Hlthcare had 52 shares outstanding in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

Gross Margin

5.8%

5Y CAGR-6.9pp

10Y CAGR-4.9pp

Molina Hlthcare's gross margin was 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

1.7%

YoY-2.5pp

5Y CAGR-3.8pp

10Y CAGR-1.0pp

Molina Hlthcare's operating margin was 1.7% in fiscal year 2025, reflecting core business profitability. This is down 2.5 percentage points from the prior year.

Net Margin

1.0%

YoY-1.9pp

5Y CAGR-2.4pp

10Y CAGR+0.0pp

Molina Hlthcare's net profit margin was 1.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.9 percentage points from the prior year.

Return on Equity

11.6%

YoY-14.6pp

5Y CAGR-20.5pp

10Y CAGR+2.4pp

Molina Hlthcare's ROE was 11.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 14.6 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$1K

YoY-100.0%

5Y CAGR-93.0%

Molina Hlthcare spent $1K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$101

YoY-100.0%

5Y CAGR-93.3%

10Y CAGR-75.5%

Molina Hlthcare invested $101 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.

MOH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$45K-100.0%	$40.6B+19.3%	$34.1B+6.6%	$32.0B+15.1%	$27.8B+43.0%	$19.4B
Cost of Revenue	$39K-100.0%	$34.4B+20.1%	$28.7B+5.5%	$27.2B+14.6%	$23.7B+49.8%	$15.8B
Gross Profit	$3K	N/A	N/A	N/A	N/A	$2.5B
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$3K-100.0%	$2.7B+11.4%	$2.5B+6.5%	$2.3B+11.8%	$2.1B+39.7%	$1.5B
Operating Income	$781-100.0%	$1.7B+8.5%	$1.6B+34.1%	$1.2B+15.0%	$1.0B-5.4%	$1.1B
Interest Expense	$192-100.0%	$118.0M+8.3%	$109.0M-0.9%	$110.0M-8.3%	$120.0M+17.6%	$102.0M
Income Tax	$117-100.0%	$410.0M+9.9%	$373.0M+37.6%	$271.0M+25.5%	$216.0M-25.0%	$288.0M
Net Income	$472-100.0%	$1.2B+8.1%	$1.1B+37.8%	$792.0M+20.2%	$659.0M-2.1%	$673.0M
EPS (Diluted)	$8.92-56.3%	$20.42+8.8%	$18.77+38.5%	$13.55+20.4%	$11.25+0.2%	$11.23

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$11.4B-0.9%	$11.5B+0.4%	$11.4B+2.5%	$11.1B+6.2%	$10.5B+1.5%	$10.3B+4.7%	$9.9B-0.5%	$9.9B
Cost of Revenue	$10.1B+0.9%	$10.0B+2.2%	$9.8B+3.7%	$9.5B+5.3%	$9.0B+4.2%	$8.6B+3.3%	$8.4B-0.5%	$8.4B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$795.0M+9.1%	$729.0M+2.5%	$711.0M-8.1%	$774.0M+16.4%	$665.0M-1.6%	$676.0M-2.2%	$691.0M-2.8%	$711.0M
Operating Income	-$162.0M-218.2%	$137.0M-63.3%	$373.0M-13.9%	$433.0M+13.9%	$380.0M-18.6%	$467.0M+7.6%	$434.0M+1.9%	$426.0M
Interest Expense	$52.0M+6.1%	$49.0M+2.1%	$48.0M+11.6%	$43.0M+26.5%	$34.0M+17.2%	$29.0M+3.6%	$28.0M+3.7%	$27.0M
Income Tax	-$54.0M-700.0%	$9.0M-87.1%	$70.0M-23.9%	$92.0M-3.2%	$95.0M-15.2%	$112.0M+6.7%	$105.0M+7.1%	$98.0M
Net Income	-$160.0M-302.5%	$79.0M-69.0%	$255.0M-14.4%	$298.0M+18.7%	$251.0M-23.0%	$326.0M+8.3%	$301.0M0.0%	$301.0M
EPS (Diluted)	$-2.79-284.8%	$1.51-68.2%	$4.75-12.8%	$5.45+23.0%	$4.43-21.6%	$5.65+9.3%	$5.170.0%	$5.17

MOH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$16K-100.0%	$15.6B+5.0%	$14.9B+20.9%	$12.3B+0.9%	$12.2B+28.1%	$9.5B
Current Assets	$12K-100.0%	$12.8B+1.8%	$12.5B+24.4%	$10.1B+0.2%	$10.1B+27.8%	$7.9B
Cash & Equivalents	$4K-100.0%	$4.7B-3.8%	$4.8B+21.0%	$4.0B-9.7%	$4.4B+6.8%	$4.2B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$245	N/A	N/A	N/A	N/A	N/A
Goodwill	$67-100.0%	$1.7B+34.6%	$1.2B+11.3%	$1.1B+13.5%	$982.0M+41.9%	$692.0M
Total Liabilities	$11K-100.0%	$11.1B+4.3%	$10.7B+14.2%	$9.3B-2.4%	$9.6B+28.8%	$7.4B
Current Liabilities	$7K-100.0%	$7.9B-3.3%	$8.2B+19.2%	$6.9B-2.7%	$7.0B+41.9%	$5.0B
Long-Term Debt	$4K-100.0%	$2.9B+34.1%	$2.2B+0.2%	$2.2B+0.1%	$2.2B+2.2%	$2.1B
Total Equity	$4K-100.0%	$4.5B+6.7%	$4.2B+42.2%	$3.0B+12.7%	$2.6B+25.5%	$2.1B
Retained Earnings	$4K-100.0%	$4.1B+5.2%	$3.9B+39.0%	$2.8B+16.5%	$2.4B+29.0%	$1.9B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$15.6B-0.9%	$15.7B-3.2%	$16.2B-1.1%	$16.4B+4.8%	$15.6B-0.8%	$15.8B+3.8%	$15.2B-2.1%	$15.5B
Current Assets	$12.4B-0.9%	$12.6B-4.3%	$13.1B-1.1%	$13.3B+3.8%	$12.8B-0.8%	$12.9B+4.5%	$12.3B-2.7%	$12.7B
Cash & Equivalents	$4.2B+0.6%	$4.2B-6.2%	$4.5B-7.4%	$4.9B+4.2%	$4.7B-1.5%	$4.7B+8.7%	$4.4B-3.5%	$4.5B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$2.0B	N/A	N/A	N/A	$1.7B	N/A	N/A	N/A
Total Liabilities	$11.5B-0.1%	$11.5B-0.9%	$11.6B-3.9%	$12.1B+8.5%	$11.1B+1.3%	$11.0B+6.2%	$10.3B-6.2%	$11.0B
Current Liabilities	$7.4B-1.5%	$7.5B-5.0%	$7.9B-3.4%	$8.2B+3.3%	$7.9B-5.3%	$8.3B+6.4%	$7.8B-8.0%	$8.5B
Long-Term Debt	$3.8B+2.8%	$3.7B+8.6%	$3.4B-5.6%	$3.6B+22.3%	$2.9B+25.3%	$2.3B+6.9%	$2.2B0.0%	$2.2B
Total Equity	$4.1B-2.9%	$4.2B-9.0%	$4.6B+6.8%	$4.3B-4.1%	$4.5B-5.7%	$4.8B-1.5%	$4.8B+7.8%	$4.5B
Retained Earnings	$3.6B-4.3%	$3.8B-9.5%	$4.2B+6.5%	$3.9B-4.6%	$4.1B-5.4%	$4.3B-3.6%	$4.5B+7.2%	$4.2B

MOH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$535-100.0%	$644.0M-61.3%	$1.7B+115.0%	$773.0M-63.5%	$2.1B+11.6%	$1.9B
Capital Expenditures	$101-100.0%	$100.0M+19.0%	$84.0M-7.7%	$91.0M+18.2%	$77.0M+4.1%	$74.0M
Free Cash Flow	$434-100.0%	$544.0M-65.5%	$1.6B+131.4%	$682.0M-66.6%	$2.0B+12.0%	$1.8B
Investing Cash Flow	$312+100.0%	-$464.0M+37.6%	-$744.0M+5.8%	-$790.0M+52.2%	-$1.7B-313.3%	-$400.0M
Financing Cash Flow	$170+100.0%	-$347.0M-498.3%	-$58.0M+86.8%	-$441.0M-141.0%	-$183.0M-184.3%	$217.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$1K-100.0%	$1.0B	$0-100.0%	$400.0M+212.5%	$128.0M-78.9%	$606.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$298.0M-138.4%	-$125.0M+58.6%	-$302.0M-258.9%	$190.0M+184.8%	-$224.0M-125.7%	$873.0M+498.6%	-$219.0M-202.3%	$214.0M
Capital Expenditures	-$1.0M-102.6%	$38.0M-9.5%	$42.0M+90.9%	$22.0M+100.0%	$11.0M-68.6%	$35.0M+29.6%	$27.0M0.0%	$27.0M
Free Cash Flow	-$299.0M-83.4%	-$163.0M+52.6%	-$344.0M-304.8%	$168.0M+171.5%	-$235.0M-128.0%	$838.0M+440.7%	-$246.0M-231.6%	$187.0M
Investing Cash Flow	$230.0M+198.7%	$77.0M-39.8%	$128.0M+204.1%	-$123.0M-747.4%	$19.0M+139.6%	-$48.0M-190.6%	$53.0M+110.9%	-$488.0M
Financing Cash Flow	$92.0M+141.8%	-$220.0M-16.4%	-$189.0M-228.6%	$147.0M+119.4%	$67.0M+118.4%	-$364.0M-3133.3%	$12.0M+119.4%	-$62.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$500.0M	$0-100.0%	$500.0M0.0%	$500.0M0.0%	$500.0M	$0	$0

MOH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	5.8%	N/A	N/A	N/A	N/A	12.8%
Operating Margin	1.7%-2.5pp	4.2%-0.4pp	4.6%+0.9pp	3.7%0.0pp	3.7%-1.9pp	5.5%
Net Margin	1.0%-1.9pp	2.9%-0.3pp	3.2%+0.7pp	2.5%+0.1pp	2.4%-1.1pp	3.5%
Return on Equity	11.6%-14.6pp	26.2%+0.3pp	25.9%-0.8pp	26.7%+1.7pp	25.1%-7.1pp	32.1%
Return on Assets	3.0%-4.5pp	7.5%+0.2pp	7.3%+0.9pp	6.4%+1.0pp	5.4%-1.7pp	7.1%
Current Ratio	1.69+0.1	1.62+0.1	1.54+0.1	1.47+0.0	1.43-0.2	1.59
Debt-to-Equity	0.93+0.3	0.65+0.1	0.52-0.2	0.73-0.1	0.83-0.2	1.01
FCF Margin	1.0%-0.4pp	1.3%-3.3pp	4.6%+2.5pp	2.1%-5.2pp	7.3%-2.0pp	9.4%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1.4%-2.6pp	1.2%-2.1pp	3.3%-0.6pp	3.9%+0.3pp	3.6%-0.9pp	4.5%+0.1pp	4.4%+0.1pp	4.3%
Net Margin	-1.4%-2.1pp	0.7%-1.5pp	2.2%-0.4pp	2.7%+0.3pp	2.4%-0.8pp	3.1%+0.1pp	3.0%+0.0pp	3.0%
Return on Equity	N/A	1.9%-3.7pp	5.5%-1.4pp	6.9%+1.3pp	5.6%-1.2pp	6.8%+0.6pp	6.2%-0.5pp	6.7%
Return on Assets	-1.0%-1.5pp	0.5%-1.1pp	1.6%-0.3pp	1.8%+0.2pp	1.6%-0.5pp	2.1%+0.1pp	2.0%+0.0pp	1.9%
Current Ratio	1.69+0.0	1.68+0.0	1.66+0.0	1.630.0	1.62+0.1	1.54-0.0	1.57+0.1	1.49
Debt-to-Equity	0.93+0.1	0.87+0.1	0.73-0.1	0.83+0.2	0.65+0.2	0.49+0.0	0.45-0.0	0.49
FCF Margin	-2.6%-1.2pp	-1.4%+1.6pp	-3.0%-4.5pp	1.5%+3.8pp	-2.2%-10.3pp	8.1%+10.6pp	-2.5%-4.4pp	1.9%

Similar Companies

Centene Corp Del CNC

$20.0B

Humana HUM

$22.1B

Elevance Health Inc ELV

$76.5B

Cvs Health Corp CVS

$99.8B

Cigna Group CI

$76.8B

Frequently Asked Questions

What is Molina Hlthcare's annual revenue?

Molina Hlthcare (MOH) reported $45K in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Molina Hlthcare's revenue growing?

Molina Hlthcare (MOH) revenue declined by 100% year-over-year, from $40.6B to $45K in fiscal year 2025.

Is Molina Hlthcare profitable?

Yes, Molina Hlthcare (MOH) reported a net income of $472 in fiscal year 2025, with a net profit margin of 1.0%.

What is Molina Hlthcare's earnings per share (EPS)?

Molina Hlthcare (MOH) reported diluted earnings per share of $8.92 for fiscal year 2025. This represents a -56.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Molina Hlthcare's EBITDA?

Molina Hlthcare (MOH) had EBITDA of $976 in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Molina Hlthcare have?

As of fiscal year 2025, Molina Hlthcare (MOH) had $4K in cash and equivalents against $4K in long-term debt.

What is Molina Hlthcare's gross margin?

Molina Hlthcare (MOH) had a gross margin of 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Molina Hlthcare's operating margin?

Molina Hlthcare (MOH) had an operating margin of 1.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Molina Hlthcare's net profit margin?

Molina Hlthcare (MOH) had a net profit margin of 1.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Molina Hlthcare's return on equity (ROE)?

Molina Hlthcare (MOH) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Molina Hlthcare's free cash flow?

Molina Hlthcare (MOH) generated $434 in free cash flow during fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Molina Hlthcare's operating cash flow?

Molina Hlthcare (MOH) generated $535 in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Molina Hlthcare's total assets?

Molina Hlthcare (MOH) had $16K in total assets as of fiscal year 2025, including both current and long-term assets.

What are Molina Hlthcare's capital expenditures?

Molina Hlthcare (MOH) invested $101 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Molina Hlthcare buy back shares?

Yes, Molina Hlthcare (MOH) spent $1K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Molina Hlthcare have outstanding?

Molina Hlthcare (MOH) had 52 shares outstanding as of fiscal year 2025.

What is Molina Hlthcare's current ratio?

Molina Hlthcare (MOH) had a current ratio of 1.69 as of fiscal year 2025, which is generally considered healthy.

What is Molina Hlthcare's debt-to-equity ratio?

Molina Hlthcare (MOH) had a debt-to-equity ratio of 0.93 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Molina Hlthcare's return on assets (ROA)?

Molina Hlthcare (MOH) had a return on assets of 3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Molina Hlthcare's Altman Z-Score?

Molina Hlthcare (MOH) has an Altman Z-Score of 363841.55, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Molina Hlthcare's Piotroski F-Score?

Molina Hlthcare (MOH) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Molina Hlthcare's earnings high quality?

Molina Hlthcare (MOH) has an earnings quality ratio of 1.13x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Molina Hlthcare cover its interest payments?

Molina Hlthcare (MOH) has an interest coverage ratio of 4.1x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Molina Hlthcare?

Molina Hlthcare (MOH) scores 31 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.